Cytek® Biosciences Names William McCombe Chief Financial Officer
FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies. He was CFO at Velo3D, a leader in metal 3D printing systems for the aerospace and other industries, CFO at HZO, a leader in delivering protective nano coatings for electronics, and EVP and CFO at Maxar Technologies, a multi-billion-dollar revenue satellite and space imaging company.
- FREMONT, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately.
- McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies.
- McCombe has significant experience in financial management, public company reporting and operational finance, and a proven track record of driving growth and building high-performance teams.
- Jeanmonod served as Cytek’s chief financial officer since 2018.